A study to compare efficacy and safety of levocetrizine versus levocetrizine alongwith probiotic in allergic rhinitis patient
Phase 4
- Conditions
- Health Condition 1: J309- Allergic rhinitis, unspecified
- Registration Number
- CTRI/2023/11/059620
- Lead Sponsor
- Shujauddin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Seasonal/Throughout year rhinitis
2. Patients with a symptom severity score of least 6 out of 15
3. Patients who were not on any anti-allergy preparations for at least 15 days
Exclusion Criteria
1. Patients below 18 years of age
2. Pregnant women
3. Allergic rhinitis with nasal polyps
4. Fungal rhinitis
5. Vasomotor rhinitis
6. Patients with history of asthma and non-allergic causes of rhinitis
7. Patients with rhinosinusitis other than allergic rhinitis
8. Patients with sino-nasal tumours
9. Recurrence/Post surgical rhinitis
10. Patients with co morbid condition (renal, hepatic, cardiac, endocrine)
11. Patient who will not come for follow-up visit
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate and compare the efficacy of Oral Levocetirizine versus Oral Levocetirizine and Oral Probiotics in patient with allergic rhinitis <br/ ><br>Outcome will be assessed by Change in the Total Nasal Symptom score throughout the study periodTimepoint: first day, 2nd week, 6th week, 12th week
- Secondary Outcome Measures
Name Time Method 1. Safety profile of Oral Levocetirizine versus Oral Levocetirizine and Oral Probiotics in patient with allergic rhinitis. <br/ ><br> <br/ ><br>Timepoint: first day, 2nd week, 6th week 12th wee;Measure the Quality of Life in patients of allergic rhinitis on Oral Levocetirizine versus Oral Levocetirizine and Oral Probiotics by Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ).Timepoint: first day, 2nd week, 6th week, 12th week